<?xml version="1.0"?>

<document>
	<title>Pseudomonas aeruginosa infection in cystic fibrosis.  Distribution
   of B and T lymphocytes in relation to the humoral immune response.</title>

	<author>Hoiby-N.</author>
	<author>Mathiesen-L.</author>

	<source>Acta-Pathol-Microbiol-Scand [B]. 1974 Aug. 82(4). P 559-66.</source>

	<abstract>The influence of chronic Ps. aeruginosa infection on the occurrence
   of bone marrow-derived lymphocytes (B cells) and thymus-derived
   lymphocytes (T cells) in peripheral blood have been studied in 2
   groups of patients with cystic fibrosis.  One group (9 patients)
   suffered from chronic Ps. aeruginosa infection in the respiratory
   tract and produced multiple Ps. aeruginosa precipitins which were
   demonstrated by means of crossed immunoelectrophoresis.  The other
   group (9 patients) had never harboured Ps. aeruginosa in the
   respiratory tract and presented no demonstrable precipitins against
   this bacteria.  The lymphocytes were examined for the presence of
   2 surface markers for B cells: receptor for C3 complement component
   (EAC rosette-formation) and surface immunoglobulins
   (immunofluorescent staining), and for the presence of 1 surface
   marker for T cells: spontaneous binding of sheep red blood cells (E
   rosette-formation).  The B:T cell ratio was nearly identical in the
   2 groups of patients whereas the total numbers of B and T cells were
   significant higher in patients with chronic Ps. aeruginosa
   infection.  The number of Ps. aeruginosa precipitins per serum was
   significantly positively correlated to the total number of T cells,
   wheras the correlation with the total number of B cells was
   insignificant.</abstract>

	<majorsubject>B-LYMPHOCYTES: im</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: im</majorsubject>
	<majorsubject>IMMUNITY</majorsubject>
	<majorsubject>PSEUDOMONAS-AERUGINOSA: im</majorsubject>
	<majorsubject>PSEUDOMONAS-INFECTIONS: im</majorsubject>
	<majorsubject>RESPIRATORY-TRACT-INFECTIONS: im</majorsubject>
	<majorsubject>T-LYMPHOCYTES: im</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ANTIBODIES-BACTERIAL</minorsubject>
	<minorsubject>ANTIGENS-BACTERIAL</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>COMPLEMENT</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: mi, bl</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>IMMUNE-ADHERENCE-REACTION</minorsubject>
	<minorsubject>IMMUNE-SERA</minorsubject>
	<minorsubject>IMMUNOELECTROPHORESIS</minorsubject>
	<minorsubject>IMMUNOGLOBULINS</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>NEUTROPHILS</minorsubject>
	<minorsubject>PRECIPITINS</minorsubject>
	<minorsubject>PSEUDOMONAS-AERUGINOSA: ip</minorsubject>
	<minorsubject>RABBITS: im</minorsubject>
	<minorsubject>RESPIRATORY-TRACT-INFECTIONS: mi</minorsubject>

	<reference>001   AIUTI F               INFECT IMMUN                     8   110 973</reference>
	<reference>002   AIUTI F               CLIN EXP IMMUNOL                13   171 973</reference>
	<reference>003   BENTWICH Z            CLIN IMMUNOL IMMUNOPATHOL        1   511 973</reference>
	<reference>004   DIEM K                DOCUMENTA GEIGY SCIENTIFIC TA            962</reference>
	<reference>005   DOGGETT RG            INFECT IMMUN                     6   628 972</reference>
	<reference>006   DWYER JM              N ENGL J MED                   288  1036 973</reference>
	<reference>007   FLORESHEIM GL         AGENTS ACTIONS                   2   231 972</reference>
	<reference>008   GAJL-PECZALSKA KJ     N ENGL J MED                   288  1033 973</reference>
	<reference>009   GAJL-PECZALSKA KJ     J CLIN INVEST                   52   919 973</reference>
	<reference>010   GIFFORD RM            J S CAROLINA MED ASSOC          68   204 972</reference>
	<reference>011   GORDON DS             AM REV RESPIR DIS              108   127 973</reference>
	<reference>012   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   81   298 973</reference>
	<reference>013   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   551 974</reference>
	<reference>014   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   541 974</reference>
	<reference>015   JONDAL M              J EXP MED                      136   207 972</reference>
	<reference>016   MELLSTEDT H           CLIN EXP IMMUNOL                15   321 973</reference>
	<reference>017   ROSS GD               J CLIN INVEST                   52   377 973</reference>
	<reference>018   SHEVACH EM            IN: MOLLER G                    16     3 973</reference>
	<reference>019   STJERNSWARD J         LANCET                           1  1352 972</reference>

	<citation>1   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   551 974</citation>
	<citation>2   VERBRUGGEN R          CLIN CHEM                       21     5 975</citation>
	<citation>3   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   83   459 975</citation>
	<citation>4   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977</citation>
	<citation>5   CLARKE CW             CLIN ALLERGY                     7   527 977</citation>
	<citation>6   HOIBY N               SCAND J RESPIR DIS              58    65 977</citation>
	<citation>7   SORENSEN RU           INFECT IMMUN                    23   398 979</citation>
	<citation>8   LIEBERMAN MM          INFECT IMMUN                    29   489 980</citation>
	<citation>9   HODSON ME             THORAX                          35   801 980</citation>
	<citation>10   WILSON GB             J CLIN INVEST                   66  1010 980</citation>
	<citation>11   HARPER TB             LUNG                           157   219 980</citation>
	<citation>12   VANGEFFEL R           IMMUNOL LETTERS                  5   155 982</citation>
	<citation>13   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982</citation>
	<citation>14   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    63 982</citation>
	<citation>15   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982</citation>
	<citation>16   MARESZBABCZYSZYN J    ARCH IMMUNOL THER EXP           31   199 983</citation>
	<citation>17   SORENSEN RU           EUR J RESPIR DIS                64   524 983</citation>
	<citation>18   SPEERT DP             SURV SYNTH PATHOL RES            4    14 985</citation>
	<citation>19   KOMIYAMA K            CAN J MICROBIOL                 33    27 987</citation>

</document>
